Download PDF
1 / Pages

Other users also viewed these articles

Early outcomes in adults hospitalized with severe SARS-CoV-2 infection receiving tocilizumab Adrián Sánchez-Montalvá; Júlia Sellarés-Nadal; Juan Espinosa-Pereiro; Nuria Fernández-Hidalgo; Santiago Pérez-Hoyos; Fernando Salvador; Xavier Durà; Marta Miarons; Andrés Antón; Simeón Eremiev-Eremiev; Abiu Sempere-González; Arnau Monforte-Pallarés; Pau Bosch-Nicolau; Salvador Augustin; Júlia Sampol; Alfredo Guillén-del-Castillo; Benito Almirante;
Med Clin. 2022;158:509-18
Effect of tocilizumab versus standard of care in adults hospitalized with moderate-severe COVID-19 pneumonia Ignacio Cardona-Pascual; David Berlana; Ferran Martinez-Valle; David Campany-Herrero; José Bruno Montoro-Ronsano;
Med Clin. 2022;158:301-7
COVID-19 vaccines and herpes infection Francisco Tejada Cifuentes; Ángeles Lloret Callejo; María José Tirado Peláez;
Med Clin. 2021;157:e355-6